91É«ÇéƬ

Time

Activity

Director's welcome

Professor Michael Farrell

Director, National Drug and Alcohol Research Centre (NDARC), 91É«ÇéƬ Sydney

Panel discussion

Weight-loss drugs and substance use disorders: Could GLP-1 receptor agonists transform addiction medicine?

Ìý

Panellists:

• Professor Michael Farrell, Director of NDARC, 91É«ÇéƬ Sydney

• Dr Mary Harrod, Chief Executive of the NSW Users and AIDS Association (NUAA)

• Professor Gavan McNally, Head of the Behavioural Neuroscience Research Group at the School of Psychology, 91É«ÇéƬ Sydney

• Professor Paul Haber AM, Executive Director Research for the Sydney Local Health District; Conjoint Professor at The University of Sydney

• Professor Sallie Pearson, Director of the Medicines Intelligence Centre of Research Excellence at the School of Population Health, 91É«ÇéƬ Sydney

Ìý

Moderator: Sophie Scott OAM,ÌýAward-winning journalist and science communicator

Three decades of Drug Trends: Emerging patterns and future directions

Associate Professor Amy Peacock

Deputy Director and Drug Trends Program Lead at NDARC, 91É«ÇéƬ Sydney

Spotlight on the National Centre for Clinical Research on Emerging Drugs (NCCRED)

• Stassi Kypri:ÌýNon-prescribed ketamine use in Australia: Results from a web-based survey

• Simon Caldwell:ÌýNavigating novel benzos: The practices & experiences of people sourcing benzodiazepines from unregulated markets

• Dr Krista Siefried:ÌýGHB & its precursors in Australia: Rising harms, shifting markets, & evolving risk behaviours

Illicit drug-related harms in Australia

• Dr Michala Kowalski and Dr Nic Taylor:ÌýIllicit Alcohol in Australia: Initial availability estimates & known harms

• Dr Rachel Sutherland:ÌýShifting nicotine landscapes: Illicit tobacco, vaping, & emerging products among people who use drugs

• Scientia Associate Professor Natasa Gisev:ÌýSeasonal variations in drug-induced deaths in Australia, 2000-2021

Breakout session one: Maternal health and young people

Ìý

• Dr Alys Havard:ÌýThe effectiveness and safety of smoking cessation pharmacotherapies during pregnancy

• Dr Danielle Tran:ÌýEngagement and retention in opioid agonist treatment during pregnancy and postpartum

• Dr Bianca Varney:ÌýUse and safety of prescription opioid analgesics during pregnancy and postpartum

• Sarah Ticehurst:ÌýYouth co-design of longitudinal research: A mixed-methods evaluation of the IMPACT Youth Council

Breakout session two: Treatment and provision of care

Ìý

• Lucy Tran:ÌýThe impact of major depressive disorder on treatment outcomes for people with methamphetamine dependence

• Dr Brendan Clifford:ÌýA pilot study of Ketamine-Assisted Psychotherapy for Methamphetamine Use Disorder

• Kendal Chidwick:ÌýModels of service delivery for opioid use disorder medications: A systematic review and meta-analysis of randomised controlled trials and observational studies

• Khine Wut Yee Kyaw:ÌýPrevalence of health service utilisation prior to drug deaths: A systematic review and meta-analysis

• Dr Liam Acheson:ÌýStigma towards people who use drugs in frontline non-clinical healthcare workers

Breakout session three: Engaging communities

Ìý

• Lily Palmer:ÌýHarm reduction strategies among people who use illicit stimulants: Naloxone and drug checking in Australia

• Cilla Zhou and Jess Doumany:ÌýPartnership as method: Co-developing an evaluation framework for peer engagement in the OLAM trial

• Dr Simon Clay:Ìý‘Wherever they’re at is wherever they’re at, right?’: Substance use and informal cultures of care among members of the queer community

• Dr Peter Gates:ÌýComprehensive community initiatives: Million-dollar mistakes or the next best thing?

• Dr Emily Symes:ÌýSubstance use in trans and gender diverse adults: a global systematic review and meta-analysis

Translating research into practice

• Professor Nick Zwar:ÌýNicotine vaping products for supporting smoking cessation: strengths and weaknesses of the Australian access model

• Professor Rebecca McKetin:ÌýMirtazapine for methamphetamine use disorder: Findings from the Tina Trial and implications for clinical practice

• Scientia Professor Louisa Degenhardt and Dr Thomas Santo Jr:ÌýOpioid dependence treatment and overdose prevention: A series of systematic reviews of the current evidence

Director's closing remarks

Professor Michael Farrell